Cosmax Nbt, Inc (222040) Fair Value & Analysis
Consumer Defensive · KR · Market cap 161B KRW
Fair value as of: Jul 20, 2026
From 15 valuation models · updated 21 days ago
Share price +31.0% over the past month.
Below-average quality, and screening another 55% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (7,379 KRW). The favourable scenario is already priced in.
- Weak quality (43/100) and above fair value at the same time, the margin of safety is missing on both counts.
- A fairly wide model range (3,234 KRW to 7,379 KRW) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 20, 2026.
How to read this chart
60‑month range 2,935 KRW – 12,700 KRW · fair‑value band 3,234 KRW – 7,379 KRW · the 10,700 KRW price screens above the 4,772 KRW fair value. Dashed = 300-day average. As of Jul 20, 2026.
Analysis
Cosmax Nbt, Inc (222040) currently trades at 10,700 KRW, while our model-based Fair Value estimate is 4,772 KRW, implying the stock looks roughly 55.4% overvalued today. The Quality Score stands at 43/100 (below-average quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, Cosmax Nbt, Inc generated revenue of 309B KRW at a net margin of -1.2%. Revenue grew 29.2% year over year. It earns a return on equity of -6.0%. Net debt stands at 116B KRW. Fundamentals as of Jul 20, 2026
Our scenario range runs from 3,234 KRW (bear case) to 7,379 KRW (bull case); at 10,700 KRW, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades near its 52-week high and 274% above its 52-week low, currently above its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -3% fair-value upside, at -55%, 222040 screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 15 models by family
Widest divergence: DCF Models (10,340 KRW) versus Asset-Based (1,442 KRW). Highest evidence: Growth DCF (80).
Notify me when 222040 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 20, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 39 · Market factors (momentum, volatility) 80
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Cosmax Nbt, Inc. operates as a health functional food company in South Korea and internationally. It also provides original design and original brand manufacturing services. In addition, the company offers cosmetics, medicines, and medical supplies. It offers its products in tablets, capsules, liquid, and powder supplement form of dosages.
Full company description
Cosmax Nbt, Inc. operates as a health functional food company in South Korea and internationally. It also provides original design and original brand manufacturing services. In addition, the company offers cosmetics, medicines, and medical supplies. It offers its products in tablets, capsules, liquid, and powder supplement form of dosages. The company serves its products through business to business, distribution companies, pharmaceutical and food companies, networks, and online channels. Cosmax Nbt, Inc. was founded in 2002 and is headquartered in Seongnam-si, South Korea.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Cosmax Nbt, Inc reported revenue of 287B KRW in FY2025 versus 289B KRW in FY2021, a compound −0.2%/yr. Reported net income was −15.0B KRW in FY2025.
222040 screens 55% overvalued. Compare with Nestlé India Limited →
Peer Group
Packaged Foods · 649 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Packaged Foods median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Packaged Foods stocks, each showing price versus our Fair Value estimate (as of Jul 20, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Nestlé India Limited NESTLEIND | ₹1,427 | ₹362.37 | -75% |
| Britannia Industries Limited BRITANNIA | ₹5,413 | ₹1,870 | -65% |
| Tata Consumer Products Limited TATACONSUM | ₹1,089 | ₹327.27 | -70% |
| PT Indofood CBP Sukses Makmur Tbk ICBP | 6,650 IDR | 15,757 IDR | +137% |
| Samyang Foods Co 003230 | 1,139,000 KRW | 1,010,543 KRW | -11% |
| Patanjali Foods Limited PATANJALI | ₹413.80 | ₹157.04 | -62% |
| Vietnam Dairy Products Joint Stock Company VNM | 58,500 VND | 68,259 VND | +17% |
| PT Mayora Indah Tbk, MYOR | 1,750 IDR | 2,699 IDR | +54% |
| PT Cisarua Mountain Dairy Tbk CMRY | 4,490 IDR | 4,355 IDR | -3% |
| Nongshim Co 004370 | 348,500 KRW | 530,619 KRW | +52% |
Compare Cosmax Nbt, Inc with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is Cosmax Nbt, Inc (222040) overvalued or undervalued?
What is the fair value of 222040?
What is the quality score of 222040?
What is the revenue of Cosmax Nbt, Inc (222040)?
What is the net profit margin of 222040?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Cosmax Nbt, Inc and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.